India Fertility Monitor Market, By Modality (Hand held and Table top), By Type (Saliva based Monitor and Urine Based Monitor ), By End User, (Hospitals, Fertility Clinics, and Homecare Settings), By Region (North India, South India, East India, West India, Central India, and North East India)

Published In : Oct 2023

Code : CMI4480

Pages :165

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

India Fertility Monitor Market– Restraints

Stringent rules & regulation for IVF procedure: Factors such as stringent rules and regulations for IVF procedure and risk associated with IVF procedure are expected to hamper the growth of the India fertility monitor market over the forecast period. For instance, on April 19, 2023, according to data provided by the health ministry of India, the ministry tightened regulations for assisted reproductive technology (ART), commonly used to treat infertility through in vitro fertilization (IVF), aiming to rein in a mushrooming money-making industry. The government has told IVF clinics to follow compliance procedures with respect to the retrieval of oocytes (a developing egg in a female), limiting the number of oocytes in one cycle, and putting a cap on the number of embryos that can be transferred to the female during the treatment cycle.
Risk associated with IVF procedure

India Fertility Monitor Market– Drivers

Increasing number of Fertility Centers in India: The rising number of fertility centers in India is expected to drive demand for fertility monitor devices, which is expected to drive market growth over the forecast period in India. For instance, in December 2020, Indira IVF (In-vitro Fertilization), a chain of fertility centers in India, announced the inauguration of the fertility center in five new centers in Tier-III cities, namely Nanded, Warangal, Sirsa, and Gulbarga in Maharashtra, India.
Increasing Prevalence of Polycystic ovary syndrome (PCOS): The increasing prevalence of polycystic ovary syndrome (PCOS) is expected to drive market growth over the forecast period. For instance, in December 2022, according to data provided by the National Library of Medicine, polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder that is characterized by chronic anovulation. Irregular periods, hirsutism, and weight gain are the common symptoms of PCOS. It is the most prevailing female endocrine disorder and the pre-eminent cause of infertility, with the worldwide range of 6-26%, and in India it is 3.7-22.5%. Moreover, the prevalence of Polycystic ovary syndrome (PCOS) is 11.34% in India, where the. The PCOS prevalence rates among Chinese females varied by region; the prevalence rates of PCOS in eastern regions (7.82%) are much lower than those in central (14.24%) and western regions (13.35%).

India Fertility Monitor Market– Challenges

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020. COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, faced problems with the transportation of things from one place to another. However, the COVID-19 pandemic had a negative impact on the India fertility monitor market, owing to increasing fertility during COVID-19. For instance, in January, 2022, according to data provided by National Library of Medicine, the COVID pandemic, affect fertility behavior and intentions in many ways. Restrictions on service provision reduce access to family planning services and increase fertility in the short term. By contrast, the economic uncertainty brought about by the pandemic and its impact on mental health and well-being may reduce fertility.